Results

Total Results: 752 records

Showing results for "prevalence".
Users also searched for: communication

221. Elevated Lead, Due for retesting | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/elevated-lead-due-retesting
     December 08, 2000 - All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

222. Lead, (Age= 2 years), Due for Screening | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-age-2-years-due-screening
     December 08, 2000 - All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

223. Lead, (Age= 9-12 months), Due for Screening | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-age-9-12-months-due-screening
     December 08, 2000 - All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

224. Lead, (Age = 3 years), Due for Screening | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-age-3-years-due-screening
     December 08, 2000 - All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

225. Lead, (High risk area AND Age= 4 years), Due for Screening | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-high-risk-area-and-age-4-years-due
     December 08, 2000 - All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

226. Impact of Health Information Technology Implementation on Diabetes Process and Outcome Measures - 2012 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/impact-health-it-implementation-diabetes-process-and-outcome-measures/annual-summary/2012
     January 01, 2012 - This study is also investigating the prevalence of voluntary physician use of the DMF embedded within … (Achieved) Estimate the prevalence of physician use of the Diabetes Management Form, and the effect

227. Impact of Health IT Implementation on Diabetes Process and Outcome Measures - 2011 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/impact-health-it-implementation-diabetes-process-and-outcome-measures/annual-summary/2011
     January 01, 2011 - EHR on patient outcomes and compliance with recommended processes of diabetes care, estimating the prevalence … (Achieved) Estimate the prevalence of physician use of the Diabetes Management Form, and the effect

228. Improving Adolescent Primary Care Through An Interactive Behavioral Health Module | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/improving-adolescent-primary-care-through-interactive-behavioral-health-module
     January 01, 2023 - Interactive Behavioral Health Module Document Type: Journal Publication Research Method: Cross-Sectional (Prevalence … Interactive Behavioral Health Module Document Type: Journal Publication Research Method: Cross-Sectional (Prevalence

229. Pediatric Rules and Reminders - Elevated Lead, Due for retesting (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/lead-elevated-retesting-due.pdf
     December 08, 2000 -  All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

230. Cardio-HIT Phase II - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r18hs017160-kmetik-final-report-2009.pdf
     January 01, 2009 - Key questions for these stakeholders include the prevalence and distribution of exception reporting, … Exception and performance reporting data were used from the Cardio-HIT sites to quantify prevalence … Exception and performance reporting data were used from the Cardio-HIT sites to quantify prevalence … The prevalence and patterns of exception reporting among a random sample of EHRs-enabled practices or … This design enabled us to begin assessing the extent to which variation in prevalence and patterns of

231. Maximizing Effectiveness of E-Prescribing Between Physicians and Community Pharmacies | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/maximizing-effectiveness-e-prescribing-between-physicians-and-community
     January 01, 2023 - Physicians and Community Pharmacies Document Type: Journal Publication Research Method: Cross-Sectional (Prevalence … Pharmacies Document Type: Journal Publication Research Method: Attitude Assessment , Cross-Sectional (Prevalence

232. Impact of Health IT Implementation on Diabetes Process and Outcome Measures (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/r21hs020696-ballard-annual-summary-2012.pdf
     January 01, 2012 - This study is also investigating the prevalence of voluntary physician use of the DMF embedded within … (Achieved) • Estimate the prevalence of physician use of the Diabetes Management Form, and the effect

233. Impact of Health IT Implementation on Diabetes Process and Outcome Measures (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/2011_020696_ballard_pdf_3.pdf
     January 01, 2011 - EHR on patient outcomes and compliance with recommended processes of diabetes care, estimating the prevalence … (Achieved) • Estimate the prevalence of physician use of the Diabetes Management Form, and the effect

234. Mollon B et al. 2009 "Features predicting the success of computerized decision support for prescribing: a systematic review of randomized controlled trials." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/mollon-b-et-al-2009
     January 01, 2009 - However, with few exceptions, the prevalence of these features was similar between successful and unsuccessful

235. A Machine Learning Health System to Integrate Care for Substance Misuse and HIV Treatment and Prevention among Hospitalized Patients - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r21hs028511-held-final-report-2024.pdf
     January 01, 2024 - Incidence and Prevalence: Approximately 6% of the patients with SUDs at Rush exhibited documented … However, this figure likely underrepresents the true prevalence due to limitations associated with … the HIV prevalence … with public health goals to increase early case detection and reduce HIV transmission rates in high- prevalence … in Risk Assessment Scope Background and Context: Participants and Settings: Incidence and Prevalence

236. Pediatric Rules and Reminders - Lead, (Age= 9-12 months), Due for Screening (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-9m-12m.pdf
     December 08, 2000 -  All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

237. Pediatric Rules and Reminders - Lead, (High risk area AND Age= 4 years), Due for Screening (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-high-risk-age-4y.pdf
     December 08, 2000 -  All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

238. Pediatric Rules and Reminders - Lead, (Age= 2 years), Due for Screening (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-2y.pdf
     December 08, 2000 -  All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

239. Pediatric Rules and Reminders - Lead, (Age = 3 years), Due for Screening (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-3y.pdf
     December 08, 2000 -  All children living in communities in which the prevalence of blood lead levels requiring individual … Evidence is currently insufficient to recommend an exact community prevalence below which targeted screening … For example, among children at selected clinics in high-risk areas of Chicago in 1997, the prevalence

240. Using Information Technology for Patient-Centered Communication and Decisionmaking about Medications | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/using-information-technology-patient-centered-communication-and-decisionmaking
     January 01, 2023 - Decisionmaking about Medications Document Type: Journal Publication Research Method: Cross-Sectional (Prevalence … Decisionmaking about Medications Document Type: Journal Publication Research Method: Cross-Sectional (Prevalence